The future of liver transplantation

Texas Heart Institute Journal

Volumn 39, Issue 6, 2012, Pages 874-875

  O'Mahony, Christine A ^a   Goss, John A ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Graft survival; Liver transplantation methods mortality; Risk factors; Transplantation immunology

Indexed keywords

TACROLIMUS;

AGE DISTRIBUTION; ALBUMIN DIALYSIS; ARTICLE; AWARENESS; BIOARTIFICIAL LIVER; BLOOD GROUP ABO INCOMPATIBILITY; CADAVER DONOR; END STAGE LIVER DISEASE; HEALTH PROGRAM; HEART DEATH; HEART FAILURE; HEMODIAFILTRATION; HEMOPHILIA; HEPATITIS C VIRUS; HIGH RISK PATIENT; HOSPITAL ADMISSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERACUTE GRAFT REJECTION; IMMUNOSUPPRESSIVE TREATMENT; INTRAVENOUS DRUG ADMINISTRATION; LIFE HISTORY; LIVER GRAFT; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; LIVING DONOR; MORTALITY; NONHUMAN; ORGAN DONOR; PATIENT SELECTION; PLASMAPHERESIS; POSTOPERATIVE CARE; POSTOPERATIVE PERIOD; PRESERVATION; PRIMATE; PRISONER; PROSTITUTION; SEXUAL BEHAVIOR; SPLIT LIVER DONATION; STEATOSIS; SURGICAL TECHNIQUE; SURVIVAL RATE; SWINE; THROMBOCYTOPENIA; UNITED STATES; VIRUS INFECTION; VIRUS TRANSMISSION; VOCATIONAL EDUCATION; XENOTRANSPLANTATION;

GRAFT SURVIVAL; LIVER TRANSPLANTATION/METHODS/MORTALITY; RISK FACTORS; TRANSPLANTATION IMMUNOLOGY;

GRAFT SURVIVAL; HUMANS; LIVER FAILURE; LIVER TRANSPLANTATION; SURVIVAL RATE; TISSUE DONORS; WORLD HEALTH;

EID: 84874092826     PISSN: 07302347     EISSN: 15266702     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Starzl TE, Groth GC, Brettschneider L, Penn I, Fulginiti VA, Moon JB, et al. Orthotopic homotransplantation of the human liver. Ann Surg 1968;168(3):392-415.
2. Emre S, Schwartz ME, Altaca G, Sethi P, Fiel MI, Guy SR, et al. Safe use of hepatic allografts from donors older than 70 years. Transplantation 1996;62(1):62-65.
3. Northup PG, Argo CK, Nguyen DT, McBride MA, Kumer SC, Schmitt TM, Pruett TL. Liver allografts from hepatitis C positive donors can offer good outcomes in hepatitis C positive recipients: a US National Transplant Registry analysis. Transpl Int 2010;23(10):1038-1044.
4. Doshi MD, Hunsicker LG. Short- and long-term outcomes with the use of kidneys and livers donated after cardiac death. Am J Transplant 2007;7(1):122-129.
5. Ekser B, Gridelli B, Veroux M, Cooper DK. Clinical pig liver xenotransplantation: how far do we have to go? Xenotransplantation 2011;18(3):158-167.